Clinical implications of interleukins-31, 32, and 33 in gastric cancer

doi:10.4251/wjgo.v14.i9.1808

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3423)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

199

WORD

HTML

1682

Figures (1-5)

262

Tables (1-3)

180

Sum=2400

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

266

Download

757

Sum=1023

Sep 15, 2022 (publication date) through Nov 23, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastrointest Oncol. Sep 15, 2022; 14(9): 1808-1822
Published online Sep 15, 2022. doi: 10.4251/wjgo.v14.i9.1808

Full Size Figure Download Figure

Figure 1 Flow chart for recruitment of gastric cancer patients. GC: Gastric cancer.

Citation: Liu QH, Zhang JW, Xia L, Wise SG, Hambly BD, Tao K, Bao SS. Clinical implications of interleukins-31, 32, and 33 in gastric cancer. World J Gastrointest Oncol 2022; 14(9): 1808-1822
URL: https://www.wjgnet.com/1948-5204/full/v14/i9/1808.htm
DOI: https://dx.doi.org/10.4251/wjgo.v14.i9.1808